Master of Industrial Drug Development


Programme Description

Understand the entire drug development process from molecule to market access

Master of Industrial Drug Development is designed to meet the need for managers to coordinate the many elements involved in order to accelerate the drug development process and smooth the transition of candidate drugs to market.

Drug development is a long, complex process requiring the interaction of numerous specialist fields. Skilful coordination of all the disciplines involved, from early target identification and validation through safety and efficacy testing to market launch, can streamline the approach to the production of new medicines.

“It is essential that employees in the pharmaceutical industry understand the whole drug development process in order to appreciate their colleagues’ perspectives and objectives, to collaborate optimally and to be capable of making the right project decisions – through MIND they acquire the necessary insights and skills”

- Søren Bregenholt, Corporate Vice President, Novo Nordisk

Participant profiles

Master of Industrial Drug Development is a continuing education programme targeted at professionals in the pharmaceutical industry. Admission requires a minimum of two years of relevant work experience.

The programme is targeted at experienced people in the biotech and pharmaceutical industries, clinical research organizations, and to some extent the medico industry, who are involved in developing drugs and need an overview of the process in its entirety as well as in-depth understanding of the individual elements.

Training is tailored to project managers, group managers, divisional managers, researchers and others who have - or expect to have - responsibility for several aspects of the drug development process.

The typical participant has a background in fields such as engineering, pharmacy, chemistry, biochemistry or the health sciences. Commitment and interest in meeting professional challenges are requirements for the Master of Industrial Drug Development program.

Programme structure

Part-time study for full-time employees

The 60 ECTS credits master’s programme (equivalent to 1 year of full-time study) is designed to be completed within 2 to 6 years of part-time study. Full-time study is not an option, as many courses are only available every second year.

All courses are designed with a minimum of classroom attendance, in order to fit into a full-time busy schedule. All courses are lectured in Copenhagen, Denmark.

Programme layout

Sign up for individual courses or enrol in the full programme

The Master’s programme consists of compulsory courses (30 ECTS), elective courses (10-18 ECTS) and a master's project (12-20 ECTS).

Compulsory courses 30 ECTS
Discovery and Development of Medicines 5 ECTS
Drug Discovery 3 ECTS
Pharmacology 2,5 ECTS
Non-clinical Safety and Toxicology 2,5 ECTS
Drug Formulation and Delivery 4 ECTS
Chemical Process Development and Production of Active Pharmaceutical Ingredients (API) 3 ECTS
Drug Regulatory Affairs in Drug Development 2,5 ECTS
QA, QC, GXP for Pharmaceutical Production 2,5 ECTS
Clinical Pharmacology and Biostatistics 5 ECTS
Elective courses (preapproved)* 10-18 ECTS
Market Access for Pharmaceutical Products 3 ECTS
Quality by Design (QbD) in Pharmaceutical Development 3 ECTS
Biopharmaceuticals Drug Development 3 ECTS
Value-Based Health Care - the future for the health care sector? 3 ECTS
Master’s project 12-20 ECTS

*You need to identify relevant elective courses that support your personal study profile. The elective courses must be approved by the Board of Studies.

Learning outcome

On completion of the program, graduates will have a broad overview of and the ability to understand the connections between all stages of the development process from discovery to clinical trials, registration, and marketing.

The MIND program gives drug developers the professional building blocks to liaise with other professionals within the company as well as with external partners, thus ensuring a high and up-to-date scientific level of the work carried out in multidisciplinary project teams.

Graduates’ ability to effectively and critically evaluate each stage of the drug development process will allow them to predict future bottlenecks.

Tuition fee

  • Course fees: From DKK 10,750 to DKK 24,975
  • Full programme: From DKK 200,000

The cost for the full programme vary according to your enrolment status, choice of elective course and citizenship (see below).

The tuition fee is differentiated, but still fixed – negotiation is not an option

The Danish Government pays a Ministry subsidy for EU/EEA students, whereas all other students must pay the full course price.

  • Full course price: all non-EU/EEA citizens (actual costs)
  • Reduced course price: all EU/EEA citizens (costs partly covered through a Ministry subsidy)

The University of Copenhagen does not offer tuition remission or scholarships

The University of Copenhagen does not offer any grants or scholarships. Nor can we answer inquiries regarding funding.

Admission and application

Admission criteria for individual courses or the full programme

The same admission criteria apply, whether you wish to follow individual courses or the full programme.

  • Relevant bachelor’s degree or equivalent
  • At least two years of relevant work experience within regulatory affairs or equivalent
  • Meet the language requirements stated at the programme website

Application process

Fill out the application form via the Master’s programme website,, and remember the required documentation.

If applying for individual courses, please use the link on the individual course pages. Application deadline for typically 8 weeks prior to the first day of lecture.

The programme has rolling admission, so applications are evaluated as they come in.

Residence permits and visas

Students from non-EU/EEA countries must obtain a visa before entering Denmark. Visa requirements to enter the country vary, so you must consult the Danish embassy or consulate in your area.

Admission to a part-time study programme does not warrant a residence permit as a student. For further information, please contact the Danish Immigration Service.

  • TYPE: Continuing Professional Development
  • PLACE: University of Copenhagen, Denmark
  • DURATION: 2-6 years part-time study
  • LANGUAGE: English
  • PARTICIPANTS: Working professionals in the pharmaceutical industry
  • ADMISSION: Continually admission for individual courses and the full programme

Duration and price

Start date: Open enrolment

Duration: 2 – 6 years part-time

Price: From DKK 10,750 to DKK 25,000 per course. From DKK 200,000 for the full programme.

Deadline: Request info. The programme has a rolling admission and application are processed as they come in.

Last updated May 2019

About the School

Driven by intellectual creativity and critical thinking since 1479, researchers and students at the University of Copenhagen have expanded horizons and contributed to moving the world forward. With it ... Read More

Driven by intellectual creativity and critical thinking since 1479, researchers and students at the University of Copenhagen have expanded horizons and contributed to moving the world forward. With its 5,000 researchers and 39,000 students, the University boasts an international research and study environment and is highly ranked on the leading ranking lists of the world's best universities. Read Less